Entries in Vioxx settlement (1)
Second Podcast with Richard Nagareda on Vioxx and mass torts.
In a follow up interview to his earlier conversation with Scott Drake of LBN on the topic of Mass Torts and the recent Vioxx settlement, Professor Richard Nagareda elaborates on the Vioxx announcement, its impact on mass torts and it's implications to the attorneys and other professionals working in the mass tort field. 
You can access the full audio interview by clicking here.
The Vioxx settlement, or we should say the potential Vioxx settlement, has several issues that will be of continued interest and discussion to trial lawyers and others nationwide. The first big stumbling block is the ethical argument that was created by the defense provision that seems to require trial lawyers to actively lobby to get all of their clients to settle under the current terms of the deal, and then to agree to not represent any clients that fail to agree to settlement. This is one of the most contentious issues in the entire Vioxx agreement and one that will likely be litigated by various attorneys or brought up for discussion before various bar ethics groups in the next few weeks.
The second major issue is going to be the subrogation and medical liens that need to be resolved prior to settlement. With new podcasts from Matt Garretson about to commence on the Legal Broadcast Network you will be able to stay up to date on this vital area of this complex case and settlement.
The LBN Team
Post a Comment
